A snapshot of cancer in Chile II: an update on research, strategies and analytical frameworks for equity, innovation and national development

Simple item page
dc.coverageDOI: 10.1186/s40659-024-00574-2
dc.creatorVacarezza, Cristóbal
dc.creatorAraneda, Julieta
dc.creatorGonzalez, Pamela
dc.creatorArteaga, Oscar
dc.creatorMarcelain, Katherine
dc.creatorCastellon, Enrique A.
dc.creatorPeriera, Ana
dc.creatorKhoury, Maroun
dc.creatorMüller, Bettina
dc.creatorLecaros, Juan Alberto
dc.creatorSalas, Sofia P.
dc.creatorRiquelme, Arnoldo
dc.creatorCorvalan, Alejandro H.
dc.creatorde la Jara, Jorge Jiménez
dc.creatorFerreccio, Catterina
dc.creatorGoic, Carolina
dc.creatorNervi, Bruno
dc.creatorRoa, Juan Carlos
dc.creatorOwen, Gareth I.
dc.date2024
dc.date.accessioned2025-11-18T19:55:47Z
dc.date.available2025-11-18T19:55:47Z
dc.description<p>Introduction: Chile has achieved developed nation status and boasts a life expectancy of 81 + years; however, the healthcare and research systems are unprepared for the social and economic burden of cancer. One decade ago, the authors put forward a comprehensive analysis of cancer infrastructure, together with a series of suggestions on research orientated political policy. Objectives: Provide an update and comment on policy, infrastructure, gender equality, stakeholder participation and new challenges in national oncology. Assess the funding and distribution of cancer investigation. Present actions for the development of oncology research, innovation and patient care. Methods: Triangulating objective system metrics of economic, epidemiological, private and public sector resources together with policy analysis, we assessed cancer burden, infrastructure, and investigation. We analyzed governmental and private-sector cancer databases, complemented by interviews with cancer stakeholders. Results: Governmental policy and patient advocacy have led to the recognition of cancer burden, a cancer law, and a national cancer plan. Cancer has become the leading cause of death in Chile (59,876 cases and 31,440 cancer deaths in 2022), yet only 0.36% gross domestic product (GDP) is directed to research and development. Inequalities in treatment regimens persist. Prevention policy has lowered tobacco consumption, sugar intake via soft drinks and offered a high coverage of HPV vaccines. A high-quality cancer research community is expanding, and internationally sponsored clinical oncology trials are increasing. Conclusions: The cancer law has facilitated advancement in policy. Prevention policies have impacted tobacco and sugar intake, while gender equality and care inequality have entered the public forum. Cancer research is stagnated by the lack of investment. Implementation of a cancer registry and biobanking, reinforcement of prevention strategies, development of human resources, promotion of clinical trial infrastructure and investment in new technologies must be placed as a priority to permit advancements in innovation and equitable cancer care.</p>eng
dc.identifierhttps://investigadores.uandes.cl/en/publications/bb517a23-1c3b-405d-8bd8-cafabefa0571
dc.identifier.urihttps://repositorio.uandes.cl/handle/uandes/59443
dc.languageeng
dc.rightsinfo:eu-repo/semantics/openAccess
dc.sourcevol.57 (2024) nr.1
dc.subjectChile
dc.subjectClinical trials
dc.subjectIncidence
dc.subjectPolicy
dc.subjectResearch
dc.subjectSouth-America
dc.subjectSDG 3 - Good Health and Well-being
dc.subjectSDG 5 - Gender Equality
dc.subjectSDG 10 - Reduced Inequalities
dc.titleA snapshot of cancer in Chile II: an update on research, strategies and analytical frameworks for equity, innovation and national developmenteng
dc.typeArticleeng
dc.typeArtículospa
Files
Collections
PURE